Related Experiment Video
Updated: May 16, 2026
09:14
The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury
Published on: October 3, 2017
Taurine and atherosclerosis
1R&D Headquarters, Self Medication Business, Taisho Pharmaceutical Co Ltd, 24-1 Takada 3-chome, Toshima-ku, Tokyo, 170-8633, Japan, s-murakami@so.taisho.co.jp.
Amino Acids
|December 11, 2012
Summary
Taurine supplementation may prevent atherosclerosis, a key factor in cardiovascular diseases. This review explores how taurine impacts atherosclerosis development and its underlying mechanisms.
Area of Science:
- Cardiovascular Science
- Nutritional Biochemistry
Background:
- Atherosclerosis is a primary driver of cardiovascular diseases (CVDs) like heart attacks and strokes, contributing significantly to global mortality.
- Taurine, an abundant amino acid in mammalian tissues, is vital for numerous physiological processes.
Purpose of the Study:
- To review the impact of taurine on atherosclerosis pathogenesis.
- To discuss potential mechanisms through which taurine mitigates atherosclerosis development.
Main Methods:
- Review of existing laboratory animal studies (genetic and dietary hyperlipidemia models).
- Analysis of epidemiological data on taurine and cardiovascular health.
- Examination of scientific literature on taurine's biochemical functions.
Main Results:
- Animal studies indicate taurine supplementation retards atherosclerosis initiation and progression.
- Epidemiological data suggest a potential preventive role for taurine in cardiovascular diseases.
Conclusions:
- Taurine shows promise in retarding atherosclerosis.
- Further investigation into taurine's mechanisms against atherosclerosis is warranted.
Related Concept Videos
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:23Atherosclerosis IV: Nursing Management
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
01:29Hypertension II: Pathophysiology
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...